Improving Treatment Adherence in HIV-Infected Individuals

PHASE2CompletedINTERVENTIONAL
Enrollment

594

Participants

Timeline

Start Date

October 31, 2005

Primary Completion Date

March 31, 2008

Study Completion Date

March 31, 2008

Conditions
HIV Antiretroviral Therapy (ART) AdherenceHealth Behavior
Interventions
BEHAVIORAL

LifeWindows Intervention Sessions

At each clinical care visit, intervention arm participants use the full LifeWindows program, which includes welcome and assessment surveys and also includes the active intervention modules. ART adherence promotion intervention activities are tailored to the participant's assessment responses. Participants select which activities he or she wishes to use which culminates in an adherence specific goal.

OTHER

Control

At each clinical care visit, control arm participants use the portion of the LifeWindows software program that provides a welcome from the avatar and collection of assessment items/surveys.

Trial Locations (5)

06030-3212

University of Connecticut Health Center, Farmington

06102

Hartford Hospital, Hartford

06510

Yale-New Haven Hospital Nathan Smith Clinic, New Haven

06511

Hospital of Saint Raphael, New Haven

06708

Waterbury Hospital, Waterbury

All Listed Sponsors
collaborator

National Institute of Mental Health (NIMH)

NIH

lead

University of Connecticut

OTHER

NCT00247611 - Improving Treatment Adherence in HIV-Infected Individuals | Biotech Hunter | Biotech Hunter